Literature DB >> 33877030

A potential means to help the HPV vaccine penetrate the Japanese public while under the continued suspension of governmental recommendation.

Natsuyo Ugumori1, Yutaka Ueda2, Asami Yagi2, Hazuki Abe2, Mayu Shiomi2, Satoshi Nakagawa2, Kosuke Hiramatsu2, Ai Miyoshi2, Eiji Kobayashi2, Toshihiro Kimura2, Tadashi Kimura2, Motowo Nabeta1.   

Abstract

In Japan, the government's recommendation for the HPV vaccine has been suspended for almost 8 years. A questionnaire survey was conducted in the Tsubaki Women's Clinic, Matsuyama, Japan, to examine responses of the mothers of girls eligible for HPV vaccine before and after their doctor provided them an informative leaflet explaining the need for cervical cancer prevention.Among the 53 mothers who admitted to imposing some preconditions before being willing to encourage their daughters' HPV vaccination, 21 (40%) mothers became more willing to vaccinate their daughters immediately after receiving the cervical cancer prevention linkage explanation provided by their doctor, and seven of the mothers (33%) even returned to the clinic to get their daughter vaccinated during our study period. Logistical regression analysis revealed that having initial preconditions required for their daughters' HPV vaccination was an independent variable influencing the mothers' change of willingness to get their daughters vaccinated immediately after receiving the explanation using the leaflet.We have found that to achieve maximum effectiveness, we can use an appropriate leaflet even under suspension of the governmental recommendation. Our future efforts should be focused on those mothers who are less likely to impose preconditions on their daughter's vaccination.

Entities:  

Keywords:  HPV vaccine; clinic; decision-making capacity; leaflet; precondition; suspension of governmental recommendation

Mesh:

Substances:

Year:  2021        PMID: 33877030      PMCID: PMC8381787          DOI: 10.1080/21645515.2021.1910001

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  13 in total

1.  HPV vaccination crisis in Japan.

Authors:  Sharon J B Hanley; Eiji Yoshioka; Yoshiya Ito; Reiko Kishi
Journal:  Lancet       Date:  2015-06-27       Impact factor: 79.321

2.  Japan's failure to vaccinate girls against human papillomavirus.

Authors:  Yutaka Ueda; Takayuki Enomoto; Masayuki Sekine; Tomomi Egawa-Takata; Akiko Morimoto; Tadashi Kimura
Journal:  Am J Obstet Gynecol       Date:  2014-11-27       Impact factor: 8.661

3.  HPV vaccination in Japan: what is happening in Japan?

Authors:  Sayaka Ikeda; Yutaka Ueda; Asami Yagi; Shinya Matsuzaki; Eiji Kobayashi; Tadashi Kimura; Etsuko Miyagi; Masayuki Sekine; Takayuki Enomoto; Kazuya Kudoh
Journal:  Expert Rev Vaccines       Date:  2019-02-22       Impact factor: 5.217

4.  Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry.

Authors:  Asami Yagi; Yutaka Ueda; Mamoru Kakuda; Yusuke Tanaka; Sayaka Ikeda; Shinya Matsuzaki; Eiji Kobayashi; Toshitaka Morishima; Isao Miyashiro; Keisuke Fukui; Yuri Ito; Tomio Nakayama; Tadashi Kimura
Journal:  Cancer Res       Date:  2019-01-11       Impact factor: 12.701

5.  HPV Vaccination and the Risk of Invasive Cervical Cancer.

Authors:  Jiayao Lei; Alexander Ploner; K Miriam Elfström; Jiangrong Wang; Adam Roth; Fang Fang; Karin Sundström; Joakim Dillner; Pär Sparén
Journal:  N Engl J Med       Date:  2020-10-01       Impact factor: 91.245

6.  Dynamic changes in Japan's prevalence of abnormal findings in cervical cervical cytology depending on birth year.

Authors:  Yutaka Ueda; Asami Yagi; Tomio Nakayama; Kei Hirai; Sayaka Ikeda; Masayuki Sekine; Etsuko Miyagi; Takayuki Enomoto
Journal:  Sci Rep       Date:  2018-04-04       Impact factor: 4.379

7.  No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: Results of the Nagoya study.

Authors:  Sadao Suzuki; Akihiro Hosono
Journal:  Papillomavirus Res       Date:  2018-02-23

8.  Corrected human papillomavirus vaccination rates for each birth fiscal year in Japan.

Authors:  Satoshi Nakagawa; Yutaka Ueda; Asami Yagi; Sayaka Ikeda; Kosuke Hiramatsu; Tadashi Kimura
Journal:  Cancer Sci       Date:  2020-04-27       Impact factor: 6.716

9.  A survey of Japanese mothers on the effectiveness of the Ministry of Health, Labor and Welfare's revised HPV vaccine leaflet.

Authors:  Mayu Shiomi; Yutaka Ueda; Hazuki Abe; Asami Yagi; Kanako Sakiyama; Tadashi Kimura; Yoshimichi Tanaka; Masahide Ohmichi; Tomoyuki Ichimura; Toshiyuki Sumi; Hiromi Murata; Hidetaka Okada; Hidekatsu Nakai; Noriomi Matsumura; Junko Saito; Tetsu Takagi; Yorihiko Horikoshi; Kentaro Shimura
Journal:  Hum Vaccin Immunother       Date:  2020-04-03       Impact factor: 3.452

View more
  1 in total

1.  Changing trends in HPV vaccination in Japan.

Authors:  Mugen Ujiie; Taito Kitano; Shinya Tsuzuki
Journal:  Hum Vaccin Immunother       Date:  2021-10-07       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.